Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Kraft Heinz
KHC
$31.1B
| $185M | 0.08% |
4,548,593
-612,603
| -12% | -$25.8M |
|
252
Southwest Airlines
LUV
$22.2B
| $185M | 0.08% |
3,479,919
-67,761
| -2% | -$4.06M |
|
253
OSI Systems
OSIS
$3.58B
| $184M | 0.08% |
1,810,706
-24,489
| -1% | -$2.38M |
|
|
AXON
254
Axon Enterprise
AXON
$42.4B
| $183M | 0.08% |
1,035,874
-20,580
| -2% | -$3.03M |
|
255
Bio-Techne
TECH
$11.2B
| $183M | 0.08% |
1,622,228
-472,644
| -23% | -$49.7M |
|
|
SUM
256
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $182M | 0.08% |
5,325,565
-505,671
| -9% | -$15.9M |
|
257
Rogers Corp
ROG
$2.31B
| $181M | 0.08% |
903,371
+130,289
| +17% | +$24.9M |
|
258
Constellium
CSTM
$4.02B
| $181M | 0.08% |
9,550,430
-298,702
| -3% | -$5.15M |
|
259
CBRE Group
CBRE
$42.1B
| $179M | 0.08% |
2,093,152
-130,109
| -6% | -$11.1M |
|
260
Clarivate
CLVT
$1.36B
| $178M | 0.08% |
6,476,903
+164,151
| +3% | +$4.51M |
|
261
Alibaba
BABA
$276B
| $178M | 0.08% |
782,672
-205,482
| -21% | -$45.7M |
|
262
Eaton
ETN
$155B
| $177M | 0.08% |
1,195,577
+280,378
| +31% | +$40.4M |
|
263
Parker-Hannifin
PH
$124B
| $176M | 0.08% |
571,511
+206,053
| +56% | +$63.8M |
|
264
Carlisle Companies
CSL
$13.8B
| $173M | 0.07% |
906,441
-153,842
| -15% | -$28.6M |
|
265
Marathon Petroleum
MPC
$91.2B
| $173M | 0.07% |
2,866,722
+757,914
| +36% | +$44.4M |
|
266
Lowe's Companies
LOW
$119B
| $173M | 0.07% |
891,241
-127,283
| -12% | -$24.9M |
|
|
MRTX
267
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $173M | 0.07% |
1,069,967
-86,196
| -7% | -$13.8M |
|
268
iShares Core US Aggregate Bond ETF
AGG
$138B
| $172M | 0.07% |
1,492,140
+271,368
| +22% | +$31.1M |
|
269
Synchrony
SYF
$24.5B
| $172M | 0.07% |
3,537,095
-878,612
| -20% | -$40M |
|
270
BridgeBio Pharma
BBIO
$16.5B
| $171M | 0.07% |
2,810,652
-62,531
| -2% | -$3.57M |
|
271
Entegris
ENTG
$19.2B
| $169M | 0.07% |
1,374,045
-432,124
| -24% | -$49.7M |
|
272
EnerSys
ENS
$6.94B
| $169M | 0.07% |
1,727,982
+102,547
| +6% | +$9.57M |
|
273
Zoetis
ZTS
$32.2B
| $168M | 0.07% |
898,928
+77,613
| +9% | +$13.5M |
|
|
ENV
274
DELISTED
ENVESTNET, INC.
ENV
| $167M | 0.07% |
2,195,647
-23,551
| -1% | -$1.73M |
|
275
ITT
ITT
$17.7B
| $166M | 0.07% |
1,811,441
-119,738
| -6% | -$11.1M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.